GB2048671B - Pharmaceutical composition containing dihydroegotoxine - Google Patents
Pharmaceutical composition containing dihydroegotoxineInfo
- Publication number
- GB2048671B GB2048671B GB8012357A GB8012357A GB2048671B GB 2048671 B GB2048671 B GB 2048671B GB 8012357 A GB8012357 A GB 8012357A GB 8012357 A GB8012357 A GB 8012357A GB 2048671 B GB2048671 B GB 2048671B
- Authority
- GB
- United Kingdom
- Prior art keywords
- dihydroegotoxine
- pharmaceutical composition
- composition containing
- pharmaceutical
- containing dihydroegotoxine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7910620A FR2454804B1 (en) | 1979-04-26 | 1979-04-26 | DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2048671A GB2048671A (en) | 1980-12-17 |
GB2048671B true GB2048671B (en) | 1983-07-13 |
Family
ID=9224784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8012357A Expired GB2048671B (en) | 1979-04-26 | 1980-04-15 | Pharmaceutical composition containing dihydroegotoxine |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE882913A (en) |
ES (1) | ES8103970A1 (en) |
FR (1) | FR2454804B1 (en) |
GB (1) | GB2048671B (en) |
IL (1) | IL59764A (en) |
IT (1) | IT1130109B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534139B1 (en) * | 1982-10-07 | 1986-08-29 | Laruelle Claude | NOVEL GALENIC FORM OF SULPIRIDE, METHOD FOR PREPARING SAME, AND MEDICINAL PRODUCT COMPRISING THIS NEW FORM |
FR2539995B1 (en) * | 1983-01-28 | 1985-08-16 | Sanofi Sa | PROGRAMMED RELEASE MEDICINE BASED ON ACETYLSALICYLIC ACID |
FR2539989B1 (en) * | 1983-01-28 | 1985-08-09 | Sanofi Sa | PROGRAMMED RELEASE MEDICINE COMBINING ACETYLSALICYLIC ACID WITH DIHYDROERGOTAMINE |
FR2554718B1 (en) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE |
FR2556964A1 (en) * | 1983-12-23 | 1985-06-28 | Ile De France | NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY |
US5069911A (en) * | 1985-02-05 | 1991-12-03 | Sandoz Ltd. | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
NZ286242A (en) * | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
CN102266310B (en) * | 2011-07-21 | 2014-01-15 | 佛山市隆信医药科技有限公司 | Dihydroergotoxine mesylate sustained-release capsule and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1347413A (en) * | 1963-01-29 | 1963-12-27 | Italnysco S P A | Broad-acting spherules or globules and method for their preparation |
GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
DE2010416B2 (en) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Orally applicable dosage form with sustained release effect |
DE2336218C3 (en) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Oral dosage form |
DE2546577B2 (en) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Solid substances made from polyvinylpyrrolidone and ergot alkaloids |
LU77353A1 (en) * | 1977-05-16 | 1979-01-19 |
-
1979
- 1979-04-26 FR FR7910620A patent/FR2454804B1/en not_active Expired
-
1980
- 1980-04-03 IL IL59764A patent/IL59764A/en unknown
- 1980-04-04 IT IT67531/80A patent/IT1130109B/en active
- 1980-04-15 GB GB8012357A patent/GB2048671B/en not_active Expired
- 1980-04-22 BE BE0/200324A patent/BE882913A/en not_active IP Right Cessation
- 1980-04-25 ES ES491455A patent/ES8103970A1/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
Also Published As
Publication number | Publication date |
---|---|
GB2048671A (en) | 1980-12-17 |
IL59764A (en) | 1984-06-29 |
ES491455A0 (en) | 1981-04-16 |
FR2454804A1 (en) | 1980-11-21 |
IT8067531A0 (en) | 1980-04-04 |
ES8103970A1 (en) | 1981-04-16 |
BE882913A (en) | 1980-08-18 |
FR2454804B1 (en) | 1986-11-21 |
IT1130109B (en) | 1986-06-11 |
IL59764A0 (en) | 1980-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2039738B (en) | Inflammation - preventing pharmaceutical composition | |
IL60555A0 (en) | Pharmaceutical compositions containing certain ureal derivatives | |
GB2057263B (en) | Compositions containing methylsulphonylmethane | |
JPS54132223A (en) | Novel pharmaceutical composition | |
ZA813465B (en) | Pharmaceutical composition | |
JPS52102432A (en) | Pharmaceutical composition containing pyretrinoid | |
NZ194421A (en) | 3-amino-sydnone-imines pharmaceutical compositions | |
DE3072103D1 (en) | Pharmaceutical compositions containing 3-amino-pyrazoline derivatives | |
PH16443A (en) | Substituted tetraazetricyclic compounds and their pharmaceutical compositions | |
IL61117A (en) | 2beta-acetoxymethyl-penam compounds and pharmaceutical compositions containing them | |
JPS5691075A (en) | Size composition | |
GB2048671B (en) | Pharmaceutical composition containing dihydroegotoxine | |
ZA805666B (en) | Pharmaceutical compositions containing paracetamol | |
IL60376A (en) | 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them | |
ZA802009B (en) | Pharmaceutical compounds | |
NZ192021A (en) | Pharmaceutical compositions containing aryltrifluoroethanols | |
ZA806383B (en) | Long acting pharmaceutical composition | |
DE3064666D1 (en) | Pharmaceutical compositions containing paracetamol | |
IL59177A0 (en) | Spiro-quinolylhydantoins and pharmaceutical compositions containing them | |
GB2055042B (en) | Pharmaceutical compositions containing substituted biruets compound | |
JPS54154516A (en) | Pharmaceutical composition | |
PH15118A (en) | Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same | |
NZ193533A (en) | 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions | |
DE3176849D1 (en) | Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate | |
IL60600A (en) | Pharmaceutical compositions comprising certain azolylalkenol compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 20000414 |